Verified Analyst Curated
Company Overview — Company Profile
8 pages · Historical 2022–2025 · Forecast 2025–2031
USD 499.00
PDF download · Immediate access
Overview
Hamont-Achel, founded in 1994, specialising in the design, manufacture, and distribution of minimally invasive gynaecological and assisted reproductive technology (ART) devices. European medtech ecosystem, with a primary focus on intrauterine device (IUD) insertion systems, embryo transfer catheters, and related consumables used across IVF clinical pathways. Western Europe, the Middle East, and select Asia-Pacific markets, served through a hybrid direct-sales and distributor network model.
Table of Contents
- Company Overview & Strategy
- Financial Performance (2022–2024)
- Product Portfolio
- SWOT Analysis